Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR

By afschroeder • October 30, 2026

Pogosyan A, Liu Y, Patel JA, Mahmoudi M, Xu H, Finn JP, Nguyen KL. Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR. Curr Cardiovasc Imaging Rep. 2026;19(1):7. doi: 10.1007/s12410-026-09618-5. Epub 2026 Oct 27. PMID: 42953276; PMCID: PMC13714125.

Tags: Cardiology/Epi, cardiovascular magnetic resonance, Contrast agents, ferumoxytol, Magnetic resonance imaging, Post Doc, Publications, USPIO, Veterans Administration

A New Frontier in Heart Failure: Promise and Pitfalls of Primary Prevention

Song MR, Ziaeian B. A New Frontier in Heart Failure: Promise and Pitfalls of Primary Prevention. JACC Heart Fail. 2026 Oct 28:103489. doi: 10.1016/j.jchf.2026.103489. Epub[...]

Prostate-Specific Membrane Antigen PET/CT Complements MRI for Focal Therapy Selection in Prostate Cancer: A Whole-Mount Histopathologic Study

Sonni I, Mohammadigoldar Z, Furey G, Kimura K, Movva PC, Holzgreve A, Bahri S, Sevco T, Chung A, Sisk A, Grogan T, Czernin J, Sung[...]

SARS-CoV-2-specific monoclonal antibody AER002 in Long COVID: an exploratory randomized phase 2a mechanistic trial

Peluso MJ, Ryder D, Dalhuisen T, Chu DHT, Williams MC, Rodriguez AE, LaFranchi BH, Vinden J, Fehrman EA, Huang B, Hoh R, Asare KA, Bellon[...]